(Q53633695)

16 May 2018

title

Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. (English)

1 reference

16 May 2018

spike glycoprotein [SARS-Cov]

1 reference

0 references

1 reference

1 reference

Kathryn E Follis

1

1 reference

16 May 2018

Joanne York

series ordinal

2

1 reference

16 May 2018

Jack H Nunberg

series ordinal

3

1 reference

16 May 2018

language of work or name

English

0 references

publication date

7 March 2006

1 reference

16 May 2018

published in

Virology

1 reference

16 May 2018

volume

350

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

358-369

1 reference

16 May 2018

Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Mechanisms of viral membrane fusion and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

The phylogeny of SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Identification of a virus-specified protein in the nucleus of vaccinia virus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Enveloped viruses: a common mode of membrane fusion?.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Ribonuclease S-peptide as a carrier in fusion proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Host cell proteases controlling virus pathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

A novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Structural and functional analysis of the S proteins of two human coronavirus OC43 strains adapted to growth in different cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Bats are natural reservoirs of SARS-like coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Coronavirus as a possible cause of severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Prevention of HIV infection by passive immunization with HIV immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Precursor processing by kex2/furin proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Genetic evolution and tropism of transmissible gastroenteritis coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Database of homology-derived protein structures and the structural meaning of sequence alignment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Structural basis for membrane fusion by enveloped viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

The SARS-CoV S glycoprotein: expression and functional characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

The signal peptide of the Junín arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

7 January 2021

The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

7 January 2021

Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

7 January 2021

Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

7 January 2021

Requirement of proteolytic cleavage of the murine coronavirus MHV-2 spike protein for fusion activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

7 January 2021

Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

1 reference

12 December 2020

Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases

1 reference

12 December 2020

Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo

1 reference

12 December 2020

Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2.

2 references

12 December 2020

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.003

7 January 2021

10.1016/J.VIROL.2006.02.003

Identifiers

DOI

1 reference

16 May 2018

PMC publication ID

7111780

0 references

1 reference

16 May 2018